Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expression
US11312956B2 · kind B2 · utility
1Cited by
1References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 7, 2017 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Jul 10, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/341
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nucleic acid which can inhibit expression of the MEX3B gene with low cytotoxicity as a side effect, an MEX3B gene expression inhibitor which contains said nucleic acid, a method for inhibiting MEX3B gene expression, and a prophylactic or therapeutic agent for disease caused by MEX3B gene expression are provided.This nucleic acid, which inhibits the expression of the MEX3B gene, is an antisense oligonucleotide having a sequence complementary to an oligonucleotide that contains at least 10 contiguous nucleotides in an untranslated region in an exon of the MEX3B gene, or
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.